alosetron has been researched along with Bowel Diseases, Inflammatory in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, S; Hosoya, T; Lo, MW; Matsumoto, K; Murayama, T; Takayama, H; Tashima, K | 1 |
| Camilleri, M | 2 |
2 review(s) available for alosetron and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Advances in pharmacological treatments of IBS.
Topics: Anti-Bacterial Agents; Benzyl Compounds; Carbolines; Clonidine; Humans; Indoles; Inflammatory Bowel Diseases; Neostigmine; Probiotics; Propylamines | 2004 |
Pharmacology and clinical experience with alosetron.
Topics: Animals; Carbolines; Clinical Trials as Topic; Digestive System; Drug Approval; Drug Evaluation, Preclinical; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Models, Animal; Serotonin Antagonists | 2000 |
1 other study(ies) available for alosetron and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice.
Topics: Animals; Carbolines; Dextran Sulfate; Disease Models, Animal; Electromyography; Hyperalgesia; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Nociception; Pyrazines; Pyridines; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Time Factors; TRPV Cation Channels; Tryptophan Hydroxylase; Visceral Afferents | 2012 |